Search

Search Constraints

You searched for: Author/Creator Cimmino, Flora

Search Results

1. An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma. Issue 1 (December 2016)

2. Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma. Issue 7 (27th February 2020)

3. Cover Picture: Perspectives on liquid biopsy for label‐free detection of "circulating tumor cells" through intelligent lab‐on‐chips (View 3/2020). Issue 3 (22nd September 2020)

4. Fine mapping of 2q35 high‐risk neuroblastoma locus reveals independent functional risk variants and suggests full‐length BARD1 as tumor‐suppressor. Issue 11 (4th October 2018)

5. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1. Issue 6 (4th October 2021)

6. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

7. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

8. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

9. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

10. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)